on Friday, September 6, 2013
James Allison, Ph.D., chair of The University of Texas M.D. Anderson Cancer Center Department of Immunology, was awarded the prestigious 2013 Novartis Prize for Clinical Immunology at the 15th International Congress of Immunology in Milan, Italy, on Aug. 23, 2013.
Allison, a UT Austin alumnus, received the award for his groundbreaking research in developing therapies to help enhance the body’s immune response to attack cancer.
He was one of only three scientists to receive the award, which was established in 1990 by Basel, Switzerland-based Novartis, a multinational pharmaceutical company. The Novartis Prizes for Immunology are awarded every three years for breakthrough contributions to the fields of basic and clinical immunology as judged by an independent panel of experts.
A native of Alice, Texas, Allison earned his bachelor’s degree in microbiology and his doctorate in biological sciences from The University of Texas at Austin. After his postdoctoral fellowship at Scripps Clinic and Research Foundation in California, Allison’s first faculty appointment was at MD Anderson’s Science Park – Research Division in Smithville, Texas, for eight years.